← FDA Drug Approvals (Drugs@FDA)

RINVOQ LQ

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2024-04-26

Drug application

FDA Application #

NDA218347

Application type

New Drug Application

Brand name

RINVOQ LQ

Generic name

UPADACITINIB

Active ingredients

UPADACITINIB

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

AbbVie Inc.

First approval

2024-04-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown